Linklaters has advised European investment firm Jacobs Capital, on its disposal of Stingray Healthcare to pan-European radiotherapy provider Amethyst Radiotherapy, a portfolio company of Fremman Capital.
With core operations in Germany and France, Stingray Healthcare operates cancer treatment centres across Europe through partnerships with cancer care professionals, providing financial resources and strategic expertise.
The cross-practice Linklaters team was led out of London by Private Equity Partner Ben Rodham, Managing Associate Martin Arnal and Associate Louisa Pratt, supported by Tax Partner Jamie Coomber and Leveraged Finance Partner Thomas Waller.
Cross-jurisdiction support was provided in Brussels by Antitrust Partner Neil Hoolihan and Managing Associate Karolis Pocius, and in Luxembourg by Corporate Counsel Maxime Bertomeu-Savalle and Managing Associate Aurelie Mounier.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
Lawyers and firms: get featured on Legal Desire
Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC.
Get featuredSubmit a press releaseThe advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
